However, the expression of RANKL in head and neck carcinomas is generally low, and the self-stimulation of RANKL expression by IL-1 would not be the major mechanism of bone resorption induced by head and neck carcinomas. The gene discussed is IL1A; the disease is head and neck carcinoma.